Moreover, the caspase inhibitor Z-VAD-FMK decreased the levels of cleaved caspase 3 in carvacrol-treated osteosarcoma cell lines (Figure 2D) and partly rescued the antiproliferative effect of carvacrol treatment in these cell lines (Figure 2E). The gene discussed is CASP3; the disease is osteosarcoma.